abrdn Life Sciences Investors (HQL) is a publicly traded Financial Services sector company. As of May 21, 2026, HQL trades at $17.22 with a market cap of $537.31M and a P/E ratio of 0.00. HQL moved +1.41% today. Year to date, HQL is +6.90%; over the trailing twelve months it is +38.84%. Its 52-week range spans $10.55 to $18.46. Rallies surfaces HQL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
abrdn Life Sciences Investors (HQL) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. HQL moved +1.41% today.
| Metric | Value |
|---|---|
| Price | $17.22 |
| Market Cap | $537.31M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.56% |
| 52-Week High | $18.46 |
| 52-Week Low | $10.55 |
| Volume | 202 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
HQL analyst coverage data. Average price target: $0.00.